Equities analysts forecast that Castlight Health, inc. (NYSE:CSLT) will post earnings of ($0.07) per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Castlight Health, inc.’s earnings, with the highest EPS estimate coming in at ($0.06) and the lowest estimate coming in at ($0.07). Castlight Health, inc. posted earnings per share of ($0.05) during the same quarter last year, which indicates a negative year over year growth rate of 40%. The firm is expected to announce its next earnings results on Wednesday, November 1st.

On average, analysts expect that Castlight Health, inc. will report full-year earnings of ($0.25) per share for the current year, with EPS estimates ranging from ($0.25) to ($0.24). For the next financial year, analysts anticipate that the firm will post earnings of ($0.09) per share, with EPS estimates ranging from ($0.17) to $0.13. Zacks’ earnings per share calculations are a mean average based on a survey of research analysts that follow Castlight Health, inc..

Castlight Health, inc. (NYSE:CSLT) last announced its quarterly earnings data on Wednesday, August 2nd. The software maker reported ($0.07) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.09) by $0.02. The company had revenue of $32.10 million for the quarter, compared to analysts’ expectations of $31.14 million. Castlight Health, inc. had a negative return on equity of 36.30% and a negative net margin of 42.54%. Castlight Health, inc.’s revenue for the quarter was up 36.0% compared to the same quarter last year. During the same period last year, the firm posted ($0.11) EPS.

A number of equities research analysts recently commented on CSLT shares. Zacks Investment Research upgraded Castlight Health, inc. from a “sell” rating to a “hold” rating in a research report on Tuesday, June 27th. BidaskClub upgraded Castlight Health, inc. from a “hold” rating to a “buy” rating in a research report on Wednesday, July 12th. ValuEngine downgraded Castlight Health, inc. from a “hold” rating to a “sell” rating in a research report on Friday, May 19th. Chardan Capital started coverage on Castlight Health, inc. in a research report on Tuesday, June 6th. They issued a “buy” rating and a $4.50 target price on the stock. Finally, Cowen and Company reiterated a “market perform” rating and issued a $4.50 target price (up from $4.00) on shares of Castlight Health, inc. in a research report on Thursday, August 3rd. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $4.57.

Shares of Castlight Health, inc. (CSLT) traded up 2.50% during trading on Friday, hitting $4.10. The company had a trading volume of 549,866 shares. Castlight Health, inc. has a 52 week low of $3.05 and a 52 week high of $5.50. The firm’s 50 day moving average is $4.01 and its 200-day moving average is $3.87. The stock’s market capitalization is $539.92 million.

In other Castlight Health, inc. news, CFO Mangini Siobhan Nolan sold 28,639 shares of the company’s stock in a transaction that occurred on Friday, August 18th. The stock was sold at an average price of $3.66, for a total transaction of $104,818.74. Following the sale, the chief financial officer now directly owns 41,622 shares in the company, valued at $152,336.52. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Giovanni M. Colella sold 8,100 shares of the company’s stock in a transaction that occurred on Thursday, August 17th. The shares were sold at an average price of $3.67, for a total value of $29,727.00. Following the sale, the insider now owns 97,969 shares in the company, valued at $359,546.23. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 208,287 shares of company stock worth $795,240. Company insiders own 37.43% of the company’s stock.

A number of hedge funds have recently modified their holdings of the business. Citadel Advisors LLC raised its position in Castlight Health, inc. by 0.7% during the second quarter. Citadel Advisors LLC now owns 105,170 shares of the software maker’s stock valued at $437,000 after purchasing an additional 713 shares during the period. Stifel Financial Corp raised its position in Castlight Health, inc. by 4.3% during the first quarter. Stifel Financial Corp now owns 36,500 shares of the software maker’s stock valued at $133,000 after purchasing an additional 1,500 shares during the period. TIAA CREF Investment Management LLC raised its position in Castlight Health, inc. by 2.1% during the first quarter. TIAA CREF Investment Management LLC now owns 108,032 shares of the software maker’s stock valued at $394,000 after purchasing an additional 2,210 shares during the period. Edge Wealth Management LLC raised its position in Castlight Health, inc. by 6.5% during the second quarter. Edge Wealth Management LLC now owns 50,050 shares of the software maker’s stock valued at $198,000 after purchasing an additional 3,050 shares during the period. Finally, Teachers Advisors LLC raised its position in Castlight Health, inc. by 8.1% during the fourth quarter. Teachers Advisors LLC now owns 62,781 shares of the software maker’s stock valued at $311,000 after purchasing an additional 4,717 shares during the period. Institutional investors and hedge funds own 41.30% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/09/10/brokerages-expect-castlight-health-inc-cslt-will-post-earnings-of-0-07-per-share.html.

Castlight Health, inc. Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Get a free copy of the Zacks research report on Castlight Health, inc. (CSLT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.